HALLE/SAALE, Germany, 25 February 2015 - Probiodrug AG ("Probiodrug", Euronext: PBD), a biopharmaceutical company developing novel therapeutic solutions to treat Alzheimer's disease, announces that Probiodrug's CEO and co-founder, Dr Konrad Glund, is scheduled to present at the following events:

(1) 8th European Life Science CEO Forum & Exhibition on Tuesday, March 3rd at 2.15pm CET in Zurich.

The Forum, is being held on the 3rd and 4th March by Sachs Associates at the Hilton Zurich Airport Hotel in Switzerland. The event brings together venture-funded and small-cap companies with leading investors, pharmaceutical companies, and scientific thought leaders.

(2) BIO-Europe Spring on Tuesday, March 10th 2015 at 12.15pm CET in Paris.

Hosted in Paris from 9th to 11th March by the EBD Group, BIO-Europe Spring is the springtime counterpart to BIO-Europe. The Conference is now in its ninth year and continues to provide life science companies with partnering opportunities.

Download : Pressemitteilung 25.02.2015